Literature DB >> 26283717

The rhetoric of female sexual dysfunction: faux feminism and the FDA.

Judy Z Segal1.   

Abstract

Entities:  

Year:  2015        PMID： 26283717      PMCID： PMC4562836          DOI： 10.1503/cmaj.150363

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Why medicalization? Introduction to the special issue on the medicalization of sex.

Authors:  Thea Cacchioni; Leonore Tiefer
Journal:  J Sex Res       Date:  2012

2.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272
  2 in total
  2 in total

1.  Female sexual dysfunction.

Authors:  Duncan S Armstrong
Journal:  CMAJ       Date:  2015-11-17       Impact factor: 8.262

2.  Preparing for the arrival of "pink Viagra": strengthening Canadian direct-to-consumer information regulations.

Authors:  Jean-Christophe Bélisle Pipon; Bryn Williams-Jones
Journal:  CMAJ       Date:  2015-12-14       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.